A Chinese robotic and artificial intelligence platform has passed the country’s national medical licensing examination, according to a report from Futurism.
The Xiaoyi robotic platform, developed by AI-company iFlytek, was originally designed to capture and analyze patient information. But the system was also able to pass the licensing test with a score of 456, 96 points higher than required, according to the report.
The development is reportedly part of the country’s efforts to integrate AI into more industries, including healthcare and consumer electronics, according to Futurism.
AI research in the country has already surpassed development in the US, and is on target to be a frontrunner by 2030, according to the report.
The Xiaoyi platform is set to be launched officially in March 2018, and is not intended to replace doctors, but to “promote better people-machine cooperation so as to boost efficiency,” iFlytek chair Liu Qingfeld told the China Daily.
The company is also hopeful that such technology would be able to improve treatments and train practitioners in China’s rural areas, where access to medical care can be harder to come by, according to the Futurism report.
According to Futurism, this growth is reported as part of the country’s efforts to integrate AAI into many sectors, including health and consumer electronics.